跳转至内容
Merck
CN

880135P

Avanti

DSPE-PEG (2000) 羧酸

Avanti Polar Lipids 880135P, powder

登录查看公司和协议定价

别名:
1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺-N-[羧基(聚乙二醇)-2000] (钠盐)
经验公式(希尔记法):
C131H257NNaO55P
分子量:
2780.38
UNSPSC代码:
12352211
NACRES:
NA.25

形式

powder

包装

pkg of 1 × 10 mg (880135P-10mg)
pkg of 1 × 100 mg (880135P-100mg)
pkg of 1 × 25 mg (880135P-25mg)
pkg of 1 × 50 mg (880135P-50mg)
pkg of 1 × 500 mg (880135P-500mg)

制造商/商品名称

Avanti Polar Lipids 880135P

运输

dry ice

储存温度

−20°C

SMILES字符串

[H][C@@](COP([O-])(OCCNC(C/C=C\OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOCCOOCC(O)=O)=O)=O)(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=

一般描述

羧酸易溶于水和乙醇等极性溶剂。DSPE-PEG(2000)羧酸由2kDa的亲水性聚乙二醇(PEG)链组成。

应用

DSPE-PEG(2000)羧酸用于:
  • 将整联蛋白 α-2(ITGA2)抗体共价结合至脂质体表面
  • 制备阿托西班结合的脂质体
  • 制备双重互补脂质体

生化/生理作用

DSPE-PEG(2000)羧酸增加脂质体的血液循环时间。DSPE-PEG(2000)羧酸的羧基有助于和抗体共价结合。

包装

20 mL 透明玻璃螺旋盖小瓶 (880135P-500 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-10 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-100 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-25 mg)
5 mL 棕色玻璃螺旋盖小瓶 (880135P-50 mg)

WGK

WGK 3

闪点(°F)

No data available

闪点(°C)

No data available


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Carboxylic Acid: Key Role in Life Sciences (2019)
ITGA2 as a potential nanotherapeutic target for glioblastoma
Guo P, et al.
Scientific reports, 9(1), 6195-6195 (2019)
Mohammad Mashreghi et al.
Nanoscale research letters, 15(1), 101-101 (2020-05-10)
In this study, we have surface-functionalized PEGylated-nanoliposomal doxorubicin (DOX) with anti-EpCAM (epithelial cell adhesion molecule) aptamer via post-insertion of anti-EpCAM aptamer-conjugated DSPE-mPEG2000 into Caelyx® (ED-lip). The size, charge, release profile, and cytotoxicity and cellular uptake of formulation were determined. The
Junxue An et al.
Journal of colloid and interface science, 577, 92-100 (2020-05-31)
Phospholipids constitute biocompatible and safe excipients for pulmonary drug delivery. They can retard the drug release and, when PEGylated, also prolong the residence time in the lung. The aim of this work was to assess the structure and coherence of
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Guo P, et al.
Science advances, 5(3), eaav5010-eaav5010 (2019)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门